{"id":"NCT03760146","sponsor":"Pfizer","briefTitle":"Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults","officialTitle":"A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN PNEUMOCOCCAL VACCINE-NAÏVE ADULTS 18 YEARS OF AGE AND OLDER","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-12-12","primaryCompletion":"2019-12-16","completion":"2019-12-16","firstPosted":"2018-11-30","resultsPosted":"2020-12-29","lastUpdate":"2021-12-02"},"enrollment":3902,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Pneumococcal Disease"],"interventions":[{"type":"BIOLOGICAL","name":"20vPnC","otherNames":[]},{"type":"BIOLOGICAL","name":"13vPnC","otherNames":[]},{"type":"BIOLOGICAL","name":"PPSV23","otherNames":["Pneumovax 23"]},{"type":"OTHER","name":"Saline","otherNames":[]}],"arms":[{"label":"60 years and above 20vPnC/Saline","type":"EXPERIMENTAL"},{"label":"60 years and above 13vPnC/PPSV23","type":"ACTIVE_COMPARATOR"},{"label":"50 through 59 years of age 20vPnC","type":"EXPERIMENTAL"},{"label":"18 through 49 years of age 20vPnC","type":"EXPERIMENTAL"},{"label":"50 through 59 years of age 13vPnC","type":"ACTIVE_COMPARATOR"},{"label":"18 through 49 years of age 13vPnC","type":"ACTIVE_COMPARATOR"}],"summary":"A Phase 3, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults","primaryOutcome":{"measure":"Percentage of Participants With Local Reactions Within 10 Days After Vaccination in All Cohorts","timeFrame":"Within 10 days after 20vPnC or 13vPnC","effectByArm":[{"arm":"Cohort 1: 20vPnC/Saline","deltaMin":7.3,"sd":null},{"arm":"Cohort 1: 13vPnC/PPSV23","deltaMin":6.2,"sd":null},{"arm":"Cohort 2: 20vPnC","deltaMin":8.2,"sd":null},{"arm":"Cohort 2: 13vPnC","deltaMin":5.4,"sd":null},{"arm":"Cohort 3: 20vPnC","deltaMin":9,"sd":null},{"arm":"Cohort 3: 13vPnC","deltaMin":9.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":68,"countries":["United States","Sweden"]},"refs":{"pmids":["36368038","34940806","34672224","32966176"],"seeAlso":["https://pmiform.com/clinical-trial-info-request?StudyID=B7471007"]},"adverseEventsSummary":{"seriousAny":{"events":36,"n":1507},"commonTop":["Injection site pain (PAIN)","Myalgia (MUSCLE PAIN)","Fatigue (FATIGUE)","Headache (HEADACHE)","Arthralgia (JOINT PAIN)"]}}